期刊文献+

沙美特罗替卡松粉吸入剂对尘肺病临床疗效的观察 被引量:2

Observation of The Clinical Efficacy of Salmeterol and Fluticasone Powdery Inhalant in Curing Pneumoconiosis
原文传递
导出
摘要 目的观察沙美特罗替卡松粉吸入剂在尘肺病治疗的效果。方法采用随机对照方法,治疗组在综合治疗基础上加用沙美特罗替卡松粉吸入剂50μg/250μg(沙美特罗/丙酸氟替松)1喷,每天2次;对照组只用综合治疗法。结果治疗后治疗组咳嗽、憋喘和肺内口罗音总有效率分别为71.05%、72.22%和57.14%,均高于对照组的28.57%,21.88%和25.00%。治疗组肺功能各项指标治疗后明显好转,与治疗前比,差异有统计学意义。结论沙美特罗替卡松粉吸入剂在改善患者临床症状和肺功能方面均明显优于对照组,对尘肺病有良好的辅助治疗作用。 [ Objective] To observe the curative effect of salmeterol and fluticasone powdery inhalant in curing pnemoconionsis. [ Methods ] Randomized controlled test was adopted. Based on the comprehensive therapy, the treatment group was treated with salmeterol and fluticasone powdery inhalant of 50 μg/250 μg, 2 times a day. The control group only received comprehensive treatment. [ Results] After treatment, the total effective rate on coughing, wheezeing and lung rale was 71.05% ,72.22% and 57.14% respectively, which was higher than that in the control group( 28.57% ,21.88% and 25.00% ). Treatment group, the indicators of lung function significantly improved after treatment, compared with the former, the difference was significant. [ Conclusion ] Salmeterol and fluticasone powdery inhalant is significantly better than the treatment in control group in terms of improving clinical symptoms and lung functions, and it has good adjuvant effect on pneumoconiosis.
作者 郭秀芝
出处 《职业与健康》 CAS 2009年第8期809-810,共2页 Occupation and Health
关键词 沙关特罗替卡松 尘肺病 肺功能 Salmeterol and fluticasone Pneumoconiosis Function
  • 相关文献

参考文献3

二级参考文献11

  • 1陈强.支气管哮喘与呼吸道重塑[J].实用儿科临床杂志,2004,19(10):819-821. 被引量:13
  • 2Eickelberg O, Roth M, Lorx R, et al. Ligand- independent activation of the glucocorticoid receptor by beta2-adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells[J ]. J Biol Chem, 1999, 274(2): 1005 被引量:1
  • 3Jenkins C, Woolcock AJ, Saarelainen B et al. Salmeterol /fluticasone Propionate combination therapy 50/ 250μg twice daily is more effective than budesonide 800μg twice daily in treating moderate to severe asthma[J]. Respir Med , 2000, 94(7):715 被引量:1
  • 4Bousquet J. Asthma. From bronchoconstriction to airways inflammation and remodeling[J] . Am J Respir Crit Care Med, 2000, 161(4): 1720 被引量:1
  • 5Van den Berg NJ. Salmeterol / fluticasone propionate (50/100mcg) in combination in a Diskus inhaler (Seretide) is effective and safe in children with asthma[J] . Paediatric Pulmonology, 2000, 10(1) :200 被引量:1
  • 6Johansson G. Comparison of Salmeterol / Fluticasone Propionate Combination With Budesonide in Patients With Mild - to- Moderate Asthma[J ] . Clin Drug Invest, 2001, 21(9) :633 被引量:1
  • 7Shrewsbury S, Pyke S, Britton M. Meta - analysis of increased does of inhaled steroid or addition of salmeterol in symptomatic asthma (MIASMA) [J ] . BMJ , 2000, 320(9):1368 被引量:1
  • 8胡亚美,江载芳.褚福棠实用儿科学[M].第7版.北京:人民卫生出版社,2002:1204 被引量:7
  • 9Eiekelberg O, Roth M, Lorx R, et al. Ligend- independent activation of the glueoeortieoid ereeptor by 132 - adrenergie erceptor agonists in primary human lung fibroblasts and vaseular smooth musele cells[J]. J Biol Mol Chem, 1999,274 : 1005 - 1010 被引量:1
  • 10Dowling RB, Jnhnson M, Cole PJ, et al. Effect of flutieasone proplonate and salmeterolon psendomonas aeruglnosa infection of the respiratory mucosa in vitro[J]. Eur Respir, 1999,14: 363- 369 被引量:1

共引文献10

同被引文献14

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部